155 related articles for article (PubMed ID: 33047629)
1. Atezolizumab-Induced Bell's Palsy in a Patient With Small Cell Lung Cancer.
Kichloo A; Albosta MS; Jamal SM; Aljadah M; Wani F; Selene I; Singh J; Taj A
J Investig Med High Impact Case Rep; 2020; 8():2324709620965010. PubMed ID: 33047629
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice guideline: Bell's palsy.
Baugh RF; Basura GJ; Ishii LE; Schwartz SR; Drumheller CM; Burkholder R; Deckard NA; Dawson C; Driscoll C; Gillespie MB; Gurgel RK; Halperin J; Khalid AN; Kumar KA; Micco A; Munsell D; Rosenbaum S; Vaughan W
Otolaryngol Head Neck Surg; 2013 Nov; 149(3 Suppl):S1-27. PubMed ID: 24189771
[TBL] [Abstract][Full Text] [Related]
3. Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication.
Zhao Y; Peng W; Abbas M; Shi M; Tang Y; Wang L; Yan H
Invest New Drugs; 2022 Feb; 40(1):209-214. PubMed ID: 34398354
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Morphological Characteristics of Anti-Programmed Death Ligand 1-Associated Retinopathy: Expanding the Spectrum of Acute Macular Neuroretinopathy.
Ramtohul P; Freund KB
Ophthalmol Retina; 2020 Apr; 4(4):446-450. PubMed ID: 31926948
[TBL] [Abstract][Full Text] [Related]
5. Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review.
Kapagan T; Aksu F; Yuzkan S; Bulut N; Erdem GU
J Oncol Pharm Pract; 2024 Jan; 30(1):201-205. PubMed ID: 37321205
[TBL] [Abstract][Full Text] [Related]
6. Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events.
Thai XC; Bruno-Murtha LA
Pharmacotherapy; 2006 Aug; 26(8):1183-9. PubMed ID: 16863496
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune Bell's Palsy Following Immunotherapy For Metastatic Melanoma: A Report of 2 Cases.
Zieman D; Frankel AE
J Immunother; 2019 Oct; 42(8):318-320. PubMed ID: 31318723
[TBL] [Abstract][Full Text] [Related]
8. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
[TBL] [Abstract][Full Text] [Related]
9. Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report.
Yamakawa H; Oba T; Ohta H; Tsukahara Y; Kida G; Tsumiyama E; Nishizawa T; Kawabe R; Sato S; Akasaka K; Amano M; Kuwano K; Matsushima H
BMC Pulm Med; 2019 Aug; 19(1):156. PubMed ID: 31438923
[TBL] [Abstract][Full Text] [Related]
10. Early-onset meningitis associated with atezolizumab treatment for non-small cell lung cancer: case report and literature review.
Ogawa K; Kaneda H; Kawamoto T; Tani Y; Izumi M; Matsumoto Y; Sawa K; Suzumura T; Watanabe T; Mitsuoka S; Asai K; Kawaguchi T
Invest New Drugs; 2020 Dec; 38(6):1901-1905. PubMed ID: 32399862
[TBL] [Abstract][Full Text] [Related]
11. Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.
Kichenadasse G; Miners JO; Mangoni AA; Rowland A; Hopkins AM; Sorich MJ
JAMA Oncol; 2020 Apr; 6(4):512-518. PubMed ID: 31876896
[TBL] [Abstract][Full Text] [Related]
12. Atezolizumab: A Review in Extensive-Stage SCLC.
Frampton JE
Drugs; 2020 Oct; 80(15):1587-1594. PubMed ID: 32990939
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Pseudoprogression During Atezolizumab Therapy
in Lung Adenocarcinoma].
Wang X; Zhao Y; Chen Z
Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):389-394. PubMed ID: 31196374
[TBL] [Abstract][Full Text] [Related]
14. Bell's palsy and autoimmunity.
Greco A; Gallo A; Fusconi M; Marinelli C; Macri GF; de Vincentiis M
Autoimmun Rev; 2012 Dec; 12(2):323-8. PubMed ID: 22684016
[TBL] [Abstract][Full Text] [Related]
15. Atezolizumab-induced myositis in a patient with small-cell lung cancer.
Sahin E; Cabuk D; Tuncer Kuru F; Yazici A
J Oncol Pharm Pract; 2024 Jan; 30(1):220-224. PubMed ID: 37750202
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial.
Pujol JL; Greillier L; Audigier-Valette C; Moro-Sibilot D; Uwer L; Hureaux J; Guisier F; Carmier D; Madelaine J; Otto J; Gounant V; Merle P; Mourlanette P; Molinier O; Renault A; Rabeau A; Antoine M; Denis MG; Bommart S; Langlais A; Morin F; Souquet PJ
J Thorac Oncol; 2019 May; 14(5):903-913. PubMed ID: 30664989
[TBL] [Abstract][Full Text] [Related]
17. Bell's palsy during interferon therapy for chronic hepatitis C infection in patients with haemorrhagic disorders.
Ogundipe O; Smith M
Haemophilia; 2000 Mar; 6(2):110-2. PubMed ID: 10781198
[TBL] [Abstract][Full Text] [Related]
18. Physical therapy for Bell's palsy (idiopathic facial paralysis).
Teixeira LJ; Valbuza JS; Prado GF
Cochrane Database Syst Rev; 2011 Dec; (12):CD006283. PubMed ID: 22161401
[TBL] [Abstract][Full Text] [Related]
19. Development of Bell's Palsy After Treatment With Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report.
Zecchini JM; Kim S; Yum K; Friedlander P
J Immunother; 2018 Jan; 41(1):39-41. PubMed ID: 28926356
[TBL] [Abstract][Full Text] [Related]
20. A case of Bell's palsy associated with blepharospasm.
Abou Dagher G; Miller J; Younes M; Tomlanovich M
J Emerg Med; 2013 Feb; 44(2):e157-9. PubMed ID: 22494605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
